Chainlink, Plexos и EDinheiro поддержат бразильскую социальную блокчейн-валюту

cryptonews.ruPublicado a 2025-05-30Actualizado a 2025-07-31

Chainlink присоединилась к институту Plexos и платформе EDinheiro в проекте по расширению финансового доступа в Бразилии через локально выпускаемые социальные валюты на базе блокчейна. Партнеры будут работать в г. Индиароба, штат Сержипи и запустят валюту Aratu. Aratu будут пользоваться около 18 000 местных жителей, которые зарабатывают на жизнь сбором моллюсков и не имеют доступа к финансовым услугам.

Социальные валюты выпускаются муниципальными или общественными банками и используются для локальных платежей и распределения помощи. Платформа EDinheiro, уже поддерживающая более 180 таких валют по всей Бразилии, будет отвечать за выпуск и управление Aratu. Технология Chainlink обеспечит безопасные связи между локальными информационными системами и блокчейн-инфраструктурой, позволяя автоматизировать отчетность, аудит и соответствие требованиям законодательства о защите данных в Бразилии.

Проект является официальным примером применения в рамках Blockchain Brazil Network (RBB) государственной инфраструктуры, созданной Федеральной Счетной палатой и Национальным банком развития. Цель RBB — повысить прозрачность и эффективность государственных программ. Институт Plexos является ассоциированным участником сети и валидатором.

Благодаря технологиям безопасности и подключения от Chainlink партнеры рассчитывают сделать социальные валюты более прозрачными и удобными в управлении. Инициатива в Индиаробе должна стать моделью для аналогичных программ в других регионах, помогая местным властям эффективно распределять помощь и стимулировать экономическую активность в малообеспеченных сообществах.

Изображение: Freepik

Criptos en tendencia

Lecturas Relacionadas

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

On August 18th, Haowei Huaxin, a semiconductor firm specializing in gallium arsenide and gallium nitride wafers, reported that over a hundred individuals forcibly entered its offices and seized the company's official seals from a safe, including the corporate, contract, and party committee seals. The incident is the latest escalation in a protracted control dispute. Haowei Huaxin, established in 2010, was originally a joint venture. Control became contested after 2021 when Zhenwei Financial Holding injected capital, becoming the largest shareholder (34.01%), while former parent Haite High-Tech's stake was diluted to 33.79%. An agreed-upon governance structure collapsed, leading to mutual accusations. Haite claimed it was locked out of the subsidiary's premises, while also alleging improper management like livestock being kept on the chip fabrication site. After state-owned Qingdao Haiyue Holdings took over Zhenwei's stake in 2023, Haite accused it of illegally seizing control. Despite Haite winning several legal battles in 2024-2026, which affirmed its rights to nominate directors and the chairman, it failed to regain physical control or recover the seals. The stakes are high: market valuations for Haite's stake in Haowei Huaxin are estimated between 3.7 to 5 billion USD, yet it is only valued at about 83 million USD on Haite's books. Losing control effectively jeopardizes a significant portion of Haite's value. In response to the seal seizure, Haite framed it as a "shareholder rights protection" action agreed upon by five shareholders. This mirrors a pattern in Chinese corporate disputes where seizing physical seals becomes a tactic to paralyze the opponent's daily operations, seen in past conflicts at companies like Dangdang and Bitmain. However, such actions don't resolve underlying ownership issues; the opposing party can report the seals stolen, declare them void, and apply for new ones, albeit with significant delay. The incident underscores how fragile corporate governance can devolve into physical confrontations over symbols of authority, with control ultimately determined by law and shareholding, not possession of a seal.

marsbitHace 24 min(s)

Haiwei Huaxin's Official Seal Seized by Over a Hundred People, High-Stakes Corporate Battle's 'Nuclear Deterrence' in Action Again

marsbitHace 24 min(s)

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

Bernstein's analysis of Moderna's 177% stock surge following positive Phase 3 results for its individualized neoantigen therapy (INT) in melanoma distinguishes fundamental drivers from market speculation. The clinical breakthrough is real: the INTerpath-001 trial met its primary and key secondary endpoints, providing crucial validation for mRNA technology in oncology beyond infectious diseases. However, Bernstein argues the magnitude of the stock move cannot be justified by this single trial's fundamentals alone. The surge was amplified by three key factors: 1) A re-rating of Moderna's mRNA platform potential for expansion into other cancers, 2) A massive short squeeze, given ~15% of shares were sold short pre-announcement, and 3) The compelling "cancer vaccine" narrative that fueled broader investor enthusiasm. While the melanoma success is significant, Bernstein cautions that replication in lung, kidney, and bladder cancers—which have different immunogenicity—is not guaranteed. Furthermore, INT's commercial model faces challenges: it's a personalized treatment, not a mass-market vaccine, implying higher production costs and potential margin pressures despite a projected multi-billion dollar peak sales opportunity. The report also notes sector rotation, with some funds moving from crowded AI/semiconductor trades into defensive healthcare stocks, adding further momentum. In conclusion, Bernstein maintains a "Market-Perform" rating and a $45 price target, far below the post-surge price. It views the current valuation as pricing in an optimistic multi-cancer platform success and efficient commercialization that are yet to be proven. The clinical inflection point is clear, but the earnings inflection point awaits validation across future trials and commercial execution.

marsbitHace 24 min(s)

Bernstein Interprets MRNA's 177% Surge: What's Fundamentals and What's Hype?

marsbitHace 24 min(s)

Trading

Spot

Artículos destacados

Cómo comprar LINK

¡Bienvenido a HTX.com! Hemos hecho que comprar ChainLink (LINK) sea simple y conveniente. Sigue nuestra guía paso a paso para iniciar tu viaje de criptos.Paso 1: crea tu cuenta HTXUtiliza tu correo electrónico o número de teléfono para registrarte y obtener una cuenta gratuita en HTX. Experimenta un proceso de registro sin complicaciones y desbloquea todas las funciones.Obtener mi cuentaPaso 2: ve a Comprar cripto y elige tu método de pagoTarjeta de crédito/débito: usa tu Visa o Mastercard para comprar ChainLink (LINK) al instante.Saldo: utiliza fondos del saldo de tu cuenta HTX para tradear sin problemas.Terceros: hemos agregado métodos de pago populares como Google Pay y Apple Pay para mejorar la comodidad.P2P: tradear directamente con otros usuarios en HTX.Over-the-Counter (OTC): ofrecemos servicios personalizados y tipos de cambio competitivos para los traders.Paso 3: guarda tu ChainLink (LINK)Después de comprar tu ChainLink (LINK), guárdalo en tu cuenta HTX. Alternativamente, puedes enviarlo a otro lugar mediante transferencia blockchain o utilizarlo para tradear otras criptomonedas.Paso 4: tradear ChainLink (LINK)Tradear fácilmente con ChainLink (LINK) en HTX's mercado spot. Simplemente accede a tu cuenta, selecciona tu par de trading, ejecuta tus trades y monitorea en tiempo real. Ofrecemos una experiencia fácil de usar tanto para principiantes como para traders experimentados.

1.2k Vistas totalesPublicado en 2024.12.13Actualizado en 2026.06.02

Cómo comprar LINK

Discusiones

Bienvenido a la comunidad de HTX. Aquí puedes mantenerte informado sobre los últimos desarrollos de la plataforma y acceder a análisis profesionales del mercado. A continuación se presentan las opiniones de los usuarios sobre el precio de LINK (LINK).

活动图片